Related Experiment Videos
[Enema therapy for ulcerative colitis patients].
Ryuichi Furuta1, Kazuo Kusugami, Hidemi Goto
1Department of Therapeutic Medicine, Nagoya University Graduate School of Medicine.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|May 11, 2005
Summary
Topical treatments for ulcerative colitis offer new options for distal colitis. Further controlled studies are needed to confirm the effectiveness of enema therapies for treating inflamed colons.
Area of Science:
- Gastroenterology
- Internal Medicine
- Pharmacology
Background:
- Therapeutic options for distal colitis have expanded in the last decade.
- Topical treatments are increasingly recognized for their potential anti-inflammatory effects in ulcerative colitis.
- Several compounds show promise with potentially lower toxicity compared to systemic treatments.
Purpose of the Study:
- To review the current therapeutic landscape for mild to moderate active distal colitis.
- To highlight the effectiveness of various topical agents in ulcerative colitis treatment.
- To identify areas for future research in enema therapy for distal colitis.
Main Methods:
- Literature review of reported therapeutic options for distal colitis.
- Analysis of studies documenting the efficacy of topical compounds.
- Assessment of anti-inflammatory effects and toxicity profiles of cited treatments.
Main Results:
- Multiple agents, including 5-aminosalicylic acid, steroids, and lidocaine gel, have demonstrated effectiveness.
- Topical application to the inflamed distal colon is a key administration route.
- These treatments present a favorable profile regarding lower toxicity.
Conclusions:
- Topical therapies represent a growing area of treatment for ulcerative colitis affecting the distal colon.
- Further large-scale, controlled studies are essential to solidify the role of enema therapy.
- Evidence suggests topical treatments may offer a valuable, less toxic approach for distal colitis management.